To investigate the role of Sharp1 in leukemia-initiating potential, we first assessed the frequency of L-GMP (Lin− c-kit+ Sca1− CD34+ CD16/32+) in MLL-AF6 AML cells by flow cytometry. Here, KMT2A is linked to acute myeloid leukemia.